Elżbieta Pluskota

2.2k total citations
56 papers, 1.7k citations indexed

About

Elżbieta Pluskota is a scholar working on Immunology and Allergy, Molecular Biology and Cell Biology. According to data from OpenAlex, Elżbieta Pluskota has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology and Allergy, 28 papers in Molecular Biology and 16 papers in Cell Biology. Recurrent topics in Elżbieta Pluskota's work include Cell Adhesion Molecules Research (37 papers), Protease and Inhibitor Mechanisms (13 papers) and Caveolin-1 and cellular processes (10 papers). Elżbieta Pluskota is often cited by papers focused on Cell Adhesion Molecules Research (37 papers), Protease and Inhibitor Mechanisms (13 papers) and Caveolin-1 and cellular processes (10 papers). Elżbieta Pluskota collaborates with scholars based in United States, Poland and United Kingdom. Elżbieta Pluskota's co-authors include Edward F. Plow, Dmitry A. Soloviev, Dorota Szpak, Dmitry A. Solovjov, Stanley E. D’Souza, Katarzyna Białkowska, Khalid Sossey‐Alaoui, Christie M. Ballantyne, Tatiana V. Byzova and Daniel I. Simon and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Blood.

In The Last Decade

Elżbieta Pluskota

54 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elżbieta Pluskota United States 25 729 571 509 333 271 56 1.7k
Valentin P. Yakubenko United States 28 528 0.7× 572 1.0× 733 1.4× 187 0.6× 188 0.7× 44 2.0k
Abigail Woodfin United Kingdom 19 919 1.3× 768 1.3× 1.2k 2.4× 167 0.5× 279 1.0× 24 2.6k
Bahare Fazeli Iran 14 814 1.1× 628 1.1× 345 0.7× 260 0.8× 368 1.4× 42 1.9k
Alfonso Luque Spain 24 1.1k 1.5× 818 1.4× 881 1.7× 555 1.7× 414 1.5× 46 2.6k
William T. Roswit United States 22 680 0.9× 338 0.6× 562 1.1× 610 1.8× 251 0.9× 25 2.2k
Carolyn A. Cuff United States 19 599 0.8× 314 0.5× 921 1.8× 205 0.6× 449 1.7× 30 2.0k
Florence Schaffner United States 22 1.1k 1.5× 272 0.5× 270 0.5× 305 0.9× 231 0.9× 26 2.1k
Timo Pikkarainen Sweden 23 752 1.0× 337 0.6× 794 1.6× 126 0.4× 264 1.0× 37 1.9k
Zoltán Jakus Hungary 22 674 0.9× 445 0.8× 994 2.0× 115 0.3× 146 0.5× 41 2.2k
Stephen N. Mueller United States 20 927 1.3× 284 0.5× 264 0.5× 203 0.6× 325 1.2× 28 1.9k

Countries citing papers authored by Elżbieta Pluskota

Since Specialization
Citations

This map shows the geographic impact of Elżbieta Pluskota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elżbieta Pluskota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elżbieta Pluskota more than expected).

Fields of papers citing papers by Elżbieta Pluskota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elżbieta Pluskota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elżbieta Pluskota. The network helps show where Elżbieta Pluskota may publish in the future.

Co-authorship network of co-authors of Elżbieta Pluskota

This figure shows the co-authorship network connecting the top 25 collaborators of Elżbieta Pluskota. A scholar is included among the top collaborators of Elżbieta Pluskota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elżbieta Pluskota. Elżbieta Pluskota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pluskota, Elżbieta, Dorota Szpak, Yunmei Wang, et al.. (2025). Kindlin-3 phosphorylation is crucial for thrombosis and hemostasis in vivo. Research and Practice in Thrombosis and Haemostasis. 9(3). 102863–102863.
2.
Szpak, Dorota, et al.. (2025). Kindlin‐2 Deletion in Mural Cells Leads to Vascular Instability. The FASEB Journal. 39(14). e70823–e70823.
3.
Białkowska, Katarzyna, Priyanka S. Rana, Wei Wang, et al.. (2024). Role of Kindlin 2 in prostate cancer. Scientific Reports. 14(1). 19809–19809. 1 indexed citations
4.
Szpak, Dorota, Katarzyna Białkowska, Kamila Bledzka, et al.. (2023). Kindlin-3 deficiency leads to impaired erythropoiesis and erythrocyte cytoskeleton. Blood Advances. 7(9). 1739–1753. 5 indexed citations
5.
Bertolini, Irene, Ekta Agarwal, Jagadish C. Ghosh, et al.. (2023). Parkin ubiquitination of Kindlin-2 enables mitochondria-associated metastasis suppression. Journal of Biological Chemistry. 299(6). 104774–104774. 3 indexed citations
6.
Plow, Edward F., Elżbieta Pluskota, & Katarzyna Białkowska. (2022). Kindlins as modulators of breast cancer progression. PubMed. 1(2). 20–29. 2 indexed citations
7.
Izem, Lahoucine, Katarzyna Białkowska, Elżbieta Pluskota, et al.. (2021). Plasminogen‐induced foam cell formation by macrophages occurs through a histone 2B (H2B)‐PAR1 pathway and requires integrity of clathrin‐coated pits. Journal of Thrombosis and Haemostasis. 19(4). 941–953. 5 indexed citations
8.
Sossey‐Alaoui, Khalid, Elżbieta Pluskota, Katarzyna Białkowska, et al.. (2017). Kindlin-2 Regulates the Growth of Breast Cancer Tumors by Activating CSF-1–Mediated Macrophage Infiltration. Cancer Research. 77(18). 5129–5141. 55 indexed citations
9.
Cui, Kui, Mitali Das, Kathleen Brown, et al.. (2017). The Upregulation of Integrin αDβ2 (CD11d/CD18) on Inflammatory Macrophages Promotes Macrophage Retention in Vascular Lesions and Development of Atherosclerosis. The Journal of Immunology. 198(12). 4855–4867. 55 indexed citations
10.
Meller, Julia, Zhihong Chen, Tejasvi Dudiki, et al.. (2017). Integrin-Kindlin3 requirements for microglial motility in vivo are distinct from those for macrophages. JCI Insight. 2(11). 23 indexed citations
11.
Xu, Zhen, Xue Chen, Huiying Zhi, et al.. (2014). Direct Interaction of Kindlin-3 With Integrin αIIbβ3 in Platelets Is Required for Supporting Arterial Thrombosis in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 34(9). 1961–1967. 37 indexed citations
12.
Pluskota, Elżbieta, Dmitry A. Soloviev, Dorota Szpak, Christian Weber, & Edward F. Plow. (2008). Neutrophil Apoptosis: Selective Regulation by Different Ligands of Integrin αMβ2. The Journal of Immunology. 181(5). 3609–3619. 39 indexed citations
13.
Soloviev, Dmitry A., William A. Fonzi, Rafael Sentandreu, et al.. (2007). Identification of pH-Regulated Antigen 1 Released from Candida albicans as the Major Ligand for Leukocyte Integrin αMβ2. The Journal of Immunology. 178(4). 2038–2046. 61 indexed citations
14.
Shi, Ting, Zhong-Hui Duan, Robert S. Papay, et al.. (2006). Novel α1-Adrenergic Receptor Signaling Pathways: Secreted Factors and Interactions with the Extracellular Matrix. Molecular Pharmacology. 70(1). 129–142. 15 indexed citations
15.
Kobylańska, Anna, et al.. (1999). The Cytotoxicity of Anti-PAI-I Oligonucleotides and Their Conjugates. Nucleosides and Nucleotides. 18(6-7). 1709–1710. 4 indexed citations
16.
Pawłowska, Zofia, Elżbieta Pluskota, Ewa Chabielska, et al.. (1998). Phosphorothioate Oligodeoxyribonucleotides Antisense to PAI-1 mRNA Increase Fibrinolysis and Modify Experimental Thrombosis in Rats. Thrombosis and Haemostasis. 79(2). 348–358. 4 indexed citations
17.
Stec, Wojciech J., Czesław S. Cierniewski, And̀rzej Okruszek, et al.. (1997). Stereodependent Inhibition of Plasminogen Activator Inhibitor Type 1 by Phosphorothioate Oligonucleotides: Proof of Sequence Specificity in Cell Culture and In Vivo Rat Experiments. Antisense and Nucleic Acid Drug Development. 7(6). 567–573. 34 indexed citations
18.
Watała, Cezary, et al.. (1996). Microenvironmental Changes in Platelet Membranes Induced by the Interaction of Fibrinogen‐Derived Peptide Ligands with Platelet Integrins. European Journal of Biochemistry. 235(1-2). 281–288. 8 indexed citations
19.
Cierniewski, Czesław S., et al.. (1996). Antigenic properties of fibrinogen component of hemaseel™ HMN subjected to the antiviral severe dry heat treatment. Thrombosis Research. 82(4). 349–359. 2 indexed citations
20.
Watała, Cezary, Krzysztof Gwoździński, Elżbieta Pluskota, et al.. (1996). Diabetes Mellitus Alters the Effect of Peptide and Protein Ligands on Membrane Fluidity of Blood Platelets. Thrombosis and Haemostasis. 75(1). 147–153. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentin P. Yakubenko Breakdown of academic impact, for papers by Abigail Woodfin Breakdown of academic impact, for papers by Bahare Fazeli Breakdown of academic impact, for papers by Alfonso Luque Breakdown of academic impact, for papers by William T. Roswit Breakdown of academic impact, for papers by Carolyn A. Cuff Breakdown of academic impact, for papers by Florence Schaffner Breakdown of academic impact, for papers by Timo Pikkarainen Breakdown of academic impact, for papers by Zoltán Jakus Breakdown of academic impact, for papers by Stephen N. Mueller
Rankless by CCL
2026